Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.745 EUR
121.75 M EUR
1.43 B EUR
202.68 M
About Hims & Hers Health, Inc.
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Founded
2017
ISIN
US4330001060
FIGI
BBG00W6VZLW4
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on HAM exchange Hims & Hers Health, Inc. Class A stocks are traded under the ticker 82W.
We've gathered analysts' opinions on Hims & Hers Health, Inc. Class A future price: according to them, 82W price has a max estimate of 71.96 EUR and a min estimate of 23.70 EUR. Watch 82W chart and read a more detailed Hims & Hers Health, Inc. Class A stock forecast: see what analysts think of Hims & Hers Health, Inc. Class A and suggest that you do with its stocks.
Yes, you can track Hims & Hers Health, Inc. Class A financials in yearly and quarterly reports right on TradingView.
Hims & Hers Health, Inc. Class A is going to release the next earnings report on Nov 3, 2025. Keep track of upcoming events with our Earnings Calendar.
82W earnings for the last quarter are 0.14 EUR per share, whereas the estimation was 0.13 EUR resulting in a 12.73% surprise. The estimated earnings for the next quarter are 0.08 EUR per share. See more details about Hims & Hers Health, Inc. Class A earnings.
Hims & Hers Health, Inc. Class A revenue for the last quarter amounts to 462.51 M EUR, despite the estimated figure of 468.31 M EUR. In the next quarter, revenue is expected to reach 493.71 M EUR.
82W net income for the last quarter is 36.08 M EUR, while the quarter before that showed 45.74 M EUR of net income which accounts for −21.12% change. Track more Hims & Hers Health, Inc. Class A financial stats to get the full picture.
No, 82W doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 15, 2025, the company has 1.64 K employees. See our rating of the largest employees — is Hims & Hers Health, Inc. Class A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hims & Hers Health, Inc. Class A EBITDA is 140.96 M EUR, and current EBITDA margin is 5.76%. See more stats in Hims & Hers Health, Inc. Class A financial statements.
Like other stocks, 82W shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hims & Hers Health, Inc. Class A stock right from TradingView charts — choose your broker and connect to your account.